IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter
Conexeu Sciences Inc.
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.
The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration.
Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis.
Ticker, listing venue and issuer profile
Pricing terms and IPO milestones
Real-time price and trading activity
USD · NASDAQ:NASDAQ:CNXU
Key valuation ratios and metrics
Balance sheet strength and liquidity
Historical financial performance
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | $11.53 | $11.88 | $10.87 | $11.73 | $11.73 | +0.20 | 29,000 |
| 2026-05-28 | $13.90 | $13.90 | $11.18 | $11.58 | $11.58 | -2.32 | 46,700 |
| 2026-05-27 | $14.22 | $14.22 | $12.50 | $13.63 | $13.63 | -0.59 | 42,400 |
| 2026-05-26 | $14.70 | $15.64 | $13.00 | $13.77 | $13.77 | -0.93 | 45,400 |
| 2026-05-22 | $13.21 | $14.68 | $12.72 | $14.40 | $14.40 | +1.19 | 31,800 |
| 2026-05-21 | $13.50 | $17.50 | $12.31 | $13.07 | $13.07 | -0.43 | 87,900 |
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| D | May 21, 2026 | Notice of Exempt Offering of Securities |
| D | May 21, 2026 | Notice of Exempt Offering of Securities |
| 424B3 | May 15, 2026 | Prospectus |
| 8-K | May 15, 2026 | Current Report |
| 424B3 | May 15, 2026 | Prospectus |
| EFFECT | May 11, 2026 | Notice of Effectiveness |
| 424B4 | May 11, 2026 | Prospectus |
| CERT | May 11, 2026 | Certification by an exchange approving securities for listing |
| 8-A12B | May 11, 2026 | Registration of securities |
| S-1/A | Apr 17, 2026 | [Amend] General form for registration of securities under the Securities Act of 1933 |
Contact and headquarters details
Key executives and officers
David R. Bogart
Founder and Director
Sonia Thomas M.B.A.
Head of Strategy and Transformation

Shares
25.27M o/s · 9.48M offered
Listing Price
$13.50
Probable listing
May 21, 2026
Sector
Healthcare